SCHEMBL7343189

SCHEMBL7343189

CCCn1nc(-c2ccccc2)nc1Cc1ccc(-c2ncccc2C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.43
AGTR1 P30556 4/20 0.40
TDP2 O95551 2/20 0.40
AGTR2 P50052 2/20 0.40
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
KDM4E B2RXH2 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
HSF1 Q00613 1/20 0.38
PPARG P37231 2/20 0.38
DHODH Q02127 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
EGFR P00533 1/20 0.38
RAF1 P04049 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7342312 0.94 NR1H3 (0.46) HDAC6AGTR1AGTR2HCRTR1HCRTR2
SCHEMBL7333814 0.93 HSF1 (0.42) HDAC6AGTR1AGTR2HSF1NR1H3
SCHEMBL7343068 0.88 AGTR1 (0.44) AGTR1AGTR2HCRTR1HCRTR2KDM4E
SCHEMBL7344708 0.88 KDM4E (0.41) AGTR1AGTR2HCRTR1HCRTR2KDM4E
SCHEMBL7344958 0.87 AGTR1 (0.38) AGTR1AGTR2HCRTR1HCRTR2KDM4E
SCHEMBL7332613 0.87 KDM4E (0.40) AGTR1AGTR2HCRTR1HCRTR2KDM4E
SCHEMBL7343123 0.86 AGTR1 (0.40) AGTR1AGTR2HCRTR1HCRTR2KDM4E
SCHEMBL9552365 0.85 AGTR1 (0.54) AGTR1AGTR2PPARG
SCHEMBL7344403 0.85 AGTR1 (0.40) AGTR1AGTR2RAB9ASMN1; SMN2
SCHEMBL7338461 0.85 AGTR1 (0.40) AGTR1AGTR2HCRTR1HCRTR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6090828-A ARTHERIOSCLEROSIS REITZ DAVID B (US) 2000-07-18 US disclosed
US-5451593-A Method of using 5-arylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of a glaucoma disorder G. D. SEARLE & CO. (US) 1995-09-19 US disclosed
US-5451591-A Method of using 5-arylheteroarylalkyl-1,3 5-trisubstituted-1,24-triazole compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1995-09-19 US disclosed
US-5196537-A Angiotensin/II/ antagonists; hypotensive agents G. D. SEARLE & CO. (US) 1993-03-23 US disclosed
WO-1992016523-A1 5-ARYLHETEROARYLALKYL-1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-10-01 WO disclosed
EP-0504888-A1 5-Arylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders G.D. Searle & Co. (US) 1992-09-23 EP disclosed